Long-Term Outcomes of Patients with Pre-Existing Essential Tremor After SARS-CoV-2 Infection
2024

Long-Term Outcomes of Patients with Essential Tremor After COVID-19

Sample size: 1074 publication 10 minutes Evidence: moderate

Author Information

Author(s): Pakan Rachel, Hadidchi Roham, Al-Ani Yousef, Piskun Hannah, Duong Katie S., Henry Sonya, Wang Stephen, Maurer Carine W., Duong Tim Q.

Primary Institution: Albert Einstein College of Medicine and Montefiore Medical Center

Hypothesis

COVID-19 exposure is associated with worse long-term outcomes in individuals with essential tremor.

Conclusion

COVID-19 significantly increases the risk of several long-term adverse health outcomes in patients with essential tremor, but does not affect mortality.

Supporting Evidence

  • COVID-19 was significantly associated with higher risk of major adverse cardiovascular events.
  • Patients with COVID-19 had a higher prevalence of type-2 diabetes, depression, and anxiety.
  • COVID-19 did not increase the risk of all-cause mortality in patients with essential tremor.
  • 65.6% of COVID-19 patients were hospitalized during their infection.
  • COVID-19 exposure was linked to new-onset sleep disturbances and fatigue.

Takeaway

This study found that people with essential tremor who had COVID-19 are more likely to have health problems like anxiety and fatigue later on, but they don't seem to die from it more than those who didn't have COVID.

Methodology

This was a retrospective study evaluating 1074 essential tremor patients from the Montefiore Health System between January 2016 and July 2023, comparing outcomes between those with and without COVID-19.

Potential Biases

Potential selection bias as the cohort may include a higher proportion of severe COVID-19 cases.

Limitations

The study is limited to patients who returned for follow-ups, may not be generalizable due to demographic factors, and did not analyze socioeconomic variables or vaccination status.

Participant Demographics

The cohort included a diverse urban population with a mean age of 66.57 years, and a higher prevalence of type-2 diabetes, depression, and anxiety in the COVID-19 group.

Statistical Information

P-Value

p<0.05

Confidence Interval

[1.49, 3.82]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/diagnostics14242774

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication